NO20032818L - Polypeptider - Google Patents

Polypeptider

Info

Publication number
NO20032818L
NO20032818L NO20032818A NO20032818A NO20032818L NO 20032818 L NO20032818 L NO 20032818L NO 20032818 A NO20032818 A NO 20032818A NO 20032818 A NO20032818 A NO 20032818A NO 20032818 L NO20032818 L NO 20032818L
Authority
NO
Norway
Prior art keywords
polypeptides
cancer
recognising
eliciting
prophylaxis
Prior art date
Application number
NO20032818A
Other languages
English (en)
Other versions
NO332137B1 (no
NO20032818D0 (no
Inventor
Gustav Gaudernack
Stein Saeboee-Larssen
Mona Moeller
Jon Amund Eriksen
Original Assignee
Gemvax As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9905720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20032818(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gemvax As filed Critical Gemvax As
Priority to NO20032818A priority Critical patent/NO332137B1/no
Publication of NO20032818D0 publication Critical patent/NO20032818D0/no
Publication of NO20032818L publication Critical patent/NO20032818L/no
Publication of NO332137B1 publication Critical patent/NO332137B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
NO20032818A 2000-12-22 2003-06-19 Polypeptid, nukleinsyre, T-lymfocytt og vektor for anvendelse innen medisin samt farmasoytisk sammensetning omfattende nevnte polypeptid. NO332137B1 (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO20032818A NO332137B1 (no) 2000-12-22 2003-06-19 Polypeptid, nukleinsyre, T-lymfocytt og vektor for anvendelse innen medisin samt farmasoytisk sammensetning omfattende nevnte polypeptid.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0031430.2A GB0031430D0 (en) 2000-12-22 2000-12-22 Polypeptides
PCT/NO2001/000498 WO2002051994A2 (en) 2000-12-22 2001-12-18 Polypeptides
NO20032818A NO332137B1 (no) 2000-12-22 2003-06-19 Polypeptid, nukleinsyre, T-lymfocytt og vektor for anvendelse innen medisin samt farmasoytisk sammensetning omfattende nevnte polypeptid.

Publications (3)

Publication Number Publication Date
NO20032818D0 NO20032818D0 (no) 2003-06-19
NO20032818L true NO20032818L (no) 2003-08-21
NO332137B1 NO332137B1 (no) 2012-07-02

Family

ID=9905720

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20032818A NO332137B1 (no) 2000-12-22 2003-06-19 Polypeptid, nukleinsyre, T-lymfocytt og vektor for anvendelse innen medisin samt farmasoytisk sammensetning omfattende nevnte polypeptid.
NO20110429A NO342257B1 (no) 2000-12-22 2011-03-21 Polypeptider, nukleinsyre-DNA og vektorer for anvendelse som et medikament i behandling av cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20110429A NO342257B1 (no) 2000-12-22 2011-03-21 Polypeptider, nukleinsyre-DNA og vektorer for anvendelse som et medikament i behandling av cancer

Country Status (14)

Country Link
US (4) US7078416B2 (no)
EP (3) EP1352056B1 (no)
JP (3) JP2004522433A (no)
AT (2) ATE358716T1 (no)
AU (3) AU2002216477B2 (no)
CA (2) CA2782510C (no)
CY (2) CY1106564T1 (no)
DE (1) DE60127715T2 (no)
DK (3) DK2361978T3 (no)
ES (2) ES2382821T3 (no)
GB (1) GB0031430D0 (no)
NO (2) NO332137B1 (no)
PT (2) PT1862544E (no)
WO (1) WO2002051994A2 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO315238B1 (no) * 1998-05-08 2003-08-04 Gemvax As Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
JP2004527449A (ja) * 2000-02-15 2004-09-09 リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア テロメラーゼ逆転写酵素を用いる癌を治療するための万能ワクチンと方法
GB0031430D0 (en) * 2000-12-22 2001-02-07 Norsk Hydro As Polypeptides
KR101455222B1 (ko) * 2002-12-16 2014-10-31 글로브이뮨 면역 요법으로서의 효모계 백신
US7439042B2 (en) * 2002-12-16 2008-10-21 Globeimmune, Inc. Yeast-based therapeutic for chronic hepatitis C infection
US8343502B2 (en) * 2002-12-16 2013-01-01 Globeimmune, Inc. Yeast-based vaccines as immunotherapy
EP1601684B1 (en) * 2003-03-05 2014-10-15 Dendreon Corporation Alternative reading frame polypeptides for treatment
EP2460533A3 (en) * 2004-10-18 2014-01-08 Globeimmune, Inc. Yeast-based therapeutic for chronic hepatitis C infection
US9732131B2 (en) 2006-02-27 2017-08-15 Calviri, Inc. Identification and use of novopeptides for the treatment of cancer
WO2010033841A1 (en) 2008-09-19 2010-03-25 Globeimmune, Inc. Immunotherapy for chronic hepatitis c virus infection
GB0821616D0 (en) 2008-11-26 2008-12-31 Lytix Biopharma As Compounds
WO2018145020A1 (en) 2017-02-03 2018-08-09 The Medical College Of Wisconsin, Inc. Kras peptide vaccine compositions and method of use
JP2020522479A (ja) 2017-06-02 2020-07-30 アリゾナ ボード オブ リージェンツ オン ビハーフ オブ アリゾナ ステート ユニバーシティ 個別化された癌ワクチンを作製する方法
US12025615B2 (en) 2017-09-15 2024-07-02 Arizona Board Of Regents On Behalf Of Arizona State University Methods of classifying response to immunotherapy for cancer
WO2021067550A1 (en) 2019-10-02 2021-04-08 Arizona Board Of Regents On Behalf Of Arizona State University Methods and compositions for identifying neoantigens for use in treating and preventing cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803070A (en) 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines
GB9103974D0 (en) 1991-02-26 1991-04-10 Norsk Hydro As Therapeutically useful peptides or peptide fragments
KR100581990B1 (ko) 1997-07-01 2006-05-23 캄비아 바이오시스템즈 엘엘씨 척추 동물 텔로머라제 유전자 및 단백질과 이의 용도
EP1068296B1 (en) * 1998-03-31 2011-08-10 Geron Corporation Compositions for eliciting an immune response to a telomerase antigen
US6337200B1 (en) 1998-03-31 2002-01-08 Geron Corporation Human telomerase catalytic subunit variants
EP0987789A4 (en) * 1998-03-31 2004-09-22 Matsushita Electric Industrial Co Ltd ANTENNA AND DIGITAL TELEVISION RECEIVER
NO315238B1 (no) 1998-05-08 2003-08-04 Gemvax As Peptider som stammer fra leserammeforskyvingsmutasjoner i TBF<beta>II- eller BAX-genet, og farmasöytiske sammensetninger inneholdende disse,nukleinsyresekvenser som koder for slike peptider, plasmider og virusvektoreromfattende slikenukleinsy
US7030211B1 (en) * 1998-07-08 2006-04-18 Gemvax As Antigenic peptides derived from telomerase
CA2368967A1 (en) * 1999-04-09 2000-10-19 Biomira, Inc. Telomerase-specific cancer vaccine
WO2000073801A2 (en) 1999-05-28 2000-12-07 Ludwig Institute For Cancer Research Breast, gastric and prostate cancer associated antigens and uses therefor
GB0031430D0 (en) * 2000-12-22 2001-02-07 Norsk Hydro As Polypeptides

Also Published As

Publication number Publication date
AU2007211889C1 (en) 2010-06-10
JP2012080883A (ja) 2012-04-26
EP1862544B2 (en) 2016-03-09
JP2014138587A (ja) 2014-07-31
PT1862544E (pt) 2012-05-07
EP2361978A1 (en) 2011-08-31
AU2010200620A1 (en) 2010-03-11
EP1862544A1 (en) 2007-12-05
AU2007211889A1 (en) 2007-09-13
US20120269858A1 (en) 2012-10-25
AU2002216477B2 (en) 2007-05-24
CY1112735T1 (el) 2016-02-10
CA2432971C (en) 2012-09-04
AU2010200620B2 (en) 2012-11-01
EP1352056B1 (en) 2007-04-04
US8193326B2 (en) 2012-06-05
WO2002051994A8 (en) 2003-03-06
US20040072759A1 (en) 2004-04-15
NO342257B1 (no) 2018-04-30
WO2002051994A2 (en) 2002-07-04
NO332137B1 (no) 2012-07-02
NO20110429L (no) 2003-08-21
ATE550426T1 (de) 2012-04-15
US7375117B2 (en) 2008-05-20
CA2782510C (en) 2014-07-15
DK2361978T3 (en) 2016-01-25
ATE358716T1 (de) 2007-04-15
DK1352056T3 (da) 2007-05-29
EP2361978B1 (en) 2015-10-14
JP2004522433A (ja) 2004-07-29
DK1862544T3 (da) 2012-07-09
CA2432971A1 (en) 2002-07-04
ES2280311T3 (es) 2007-09-16
CA2782510A1 (en) 2002-07-04
PT1352056E (pt) 2007-05-31
WO2002051994A3 (en) 2002-12-27
CY1106564T1 (el) 2012-01-25
DE60127715T2 (de) 2007-12-27
AU2007211889B8 (en) 2009-12-10
EP1862544B1 (en) 2012-03-21
NO20032818D0 (no) 2003-06-19
AU2002216477C1 (en) 2002-07-08
GB0031430D0 (en) 2001-02-07
EP1352056A2 (en) 2003-10-15
US20080187551A1 (en) 2008-08-07
US20060194731A1 (en) 2006-08-31
US7078416B2 (en) 2006-07-18
AU2007211889B2 (en) 2009-11-19
ES2382821T3 (es) 2012-06-13
DE60127715D1 (de) 2007-05-16

Similar Documents

Publication Publication Date Title
NO20110429L (no) Polypeptider og nukleinsyre-DNA for anvendelse innen medisin
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
PL366575A1 (pl) Kompozycje oraz sposoby leczenia i diagnozowania raka jajnika
CY1113421T1 (el) Πυρηνικα οξεα και πολυπεπτιδια υποδοχεα
CY1109463T1 (el) Πεπτιδια kdr και εμβολια που τα περιλαμβανουν
DE69435075D1 (de) , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten
CY1117786T1 (el) Διαφορικα εκφραζομενα σε ογκους γονιδιακα προϊοντα και χρηση αυτων
HUP0300369A2 (hu) Többértékű antitestek és alkalmazásuk
AU2003242305A1 (en) Hla-a24-restricted cancer antigen peptide
TR200102191T2 (tr) HER-2/neu füzyon proteinleri.
CY1106806T1 (el) Dna και πολυπεπτιδια ανθρωπινης tslp
EP0837928A4 (en) COMPOSITIONS OF RECOMBINED POXVIRUS-CYTOMEGALOVIRUS AND THEIR USE
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
WO2005007673A3 (en) Immunogenic peptides
ATE307889T1 (de) Agarase und gen dafür
EP1536006A4 (en) CANCER-ANIMALS AND THEIR USE
MXPA05007940A (es) Composiciones y metodos para el tratamiento del cancer usando igsf9 y liv-1.
CY1106433T1 (el) Εμβολια κοκκιδιωσης
BR0113099A (pt) Gene e proteìna relacionados com esquizofrenia
WO2003093298A3 (en) Immunogenic peptides
BR0207447A (pt) Polipeptìdeos e fragmentos de dna correspondentes de streptococcus pyogenes úteis como componentes de vacina
FR2813606B1 (fr) Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques
WO2002066652A3 (en) Ehrlichia ruminantium polypeptides, antigens, polynucleotides, and methods of use

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees